Cargando…

JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis

We analyzed reports on safety and efficacy of JAK-inhibitors in patients with coronavirus infectious disease-2019 (COVID-19) published between January 1st and March 6th 2021 using the Newcastle-Ottawa and Jadad scales for quality assessment. We used disease severity as a proxy for time when JAK-inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chong-xiang, Wang, Jiao-jiao, Li, Huan, Yuan, Le-tao, Gale, Robert Peter, Liang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119232/ https://www.ncbi.nlm.nih.gov/pubmed/33990684 http://dx.doi.org/10.1038/s41375-021-01266-6

Ejemplares similares

Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
por: Chen, Chong-xiang, et al.
Publicado: (2021)

JAK inhibitors and COVID-19
por: Levy, Gabriel, et al.
Publicado: (2022)

Correction: JAK inhibitors and COVID-19
Publicado: (2023)

Prevention and control of coronavirus disease 2019 (COVID-19) in public places()
por: Pan, Lijun, et al.
Publicado: (2022)

Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis
por: Krittanawong, Chayakrit, et al.
Publicado: (2020)

Focus on coronavirus disease 2019 associated coagulopathy
por: Yang, Xiang-Hong, et al.
Publicado: (2020)

Jak inhibitors in vitiligo: a meta analysis
por: Huang, Xinlyu, et al.
Publicado: (2023)

Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: a meta-analysis
por: Shao, Meng-Jiao, et al.
Publicado: (2020)

Small Solitary Ground-Glass Nodule on CT as an Initial Manifestation of Coronavirus Disease 2019 (COVID-19) Pneumonia
por: Xia, Tianyi, et al.
Publicado: (2020)

In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)
por: Aghaee, Elham, et al.
Publicado: (2021)

Emergency Management in a Dental Clinic During the Coronavirus Disease 2019 (COVID-19) Epidemic in Beijing
por: Wang, Chao, et al.
Publicado: (2021)

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera
por: Liu, Dan, et al.
Publicado: (2021)

Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China
por: Wu, Huan, et al.
Publicado: (2020)

Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010–2019
por: Setyawan, Juliana, et al.
Publicado: (2021)

Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis?
por: Wang, Chenxing, et al.
Publicado: (2020)

Coronavirus Disease 2019–COVID-19
por: Dhama, Kuldeep, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19)
por: Goldust, Mohamad
Publicado: (2022)

Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
por: Li, Liu-Cheng, et al.
Publicado: (2020)

Design of Clinical Trials Evaluating Ruxolitinib, a JAK1/JAK2 Inhibitor, for Treatment of COVID-19–Associated Cytokine Storm
por: Langmuir, Peter, et al.
Publicado: (2020)

Ventilation-Perfusion Scans During the Coronavirus Disease 2019 (COVID-19) Outbreak
por: Lee, Joseph C., et al.
Publicado: (2020)

Efficacy of Combination Therapy With The JAK Inhibitor Baricitinib In The Treatment of COVID-19
por: Thoms, Brendan Lawless, et al.
Publicado: (2021)

Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
por: Thoms, Brendan L., et al.
Publicado: (2022)

A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)
por: Danwang, Celestin, et al.
Publicado: (2020)

JAK Inhibitors and Oxidative Stress Control
por: Charras, Amandine, et al.
Publicado: (2019)

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
por: Fu, Leiwen, et al.
Publicado: (2020)

Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19)()
por: Shang, You, et al.
Publicado: (2022)

Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – A systematic review, meta-analysis, and meta-regression
por: Rakhmat, Iis Inayati, et al.
Publicado: (2021)

Emergence of coronavirus disease 2019 (COVID-19) in Austria
por: Kreidl, Peter, et al.
Publicado: (2020)

COVID-19 („coronavirus disease 2019“) und kein Ende?
por: Berlit, Peter
Publicado: (2021)

Clinical laboratory characteristics of severe patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
por: Li, Xiang, et al.
Publicado: (2021)

Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
por: Tian, Sufang, et al.
Publicado: (2020)

Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children
por: Hong, Hao, et al.
Publicado: (2020)

Management of acute coronary syndrome in the context of coronavirus disease 2019
por: Liang, Xi-Ying, et al.
Publicado: (2021)

Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications
por: An, Peng-jiao, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID‐19): Emerging detection technologies and auxiliary analysis
por: Chen, Ying, et al.
Publicado: (2021)

Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: A meta-analysis and meta-regression
por: Siahaan, Yusak Mangara Tua, et al.
Publicado: (2022)

Ferritin in the coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
por: Cheng, Linlin, et al.
Publicado: (2020)

Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
por: Huang, Ian, et al.
Publicado: (2020)

A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
por: Zhuang, Jieqin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2r1t3r533fe5tgg5aaa31a8pnu